Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates

By Baqar S.   Bourgeois A.L.   Schultheiss P.J.   Walker R.I.   Rollins D.M.   Haberberger R.L.   Pavlovskis O.R.  

Vaccine, Vol. 13, Iss. 1, 1995-01 ,pp. : 22-28

Elsevier

Access to resources Recommend Favorite

A hepatitis B vaccine formulated with a novel adjuvant system

By Ambrosch F.   Wiedermann G.   Kundi M.   Leroux-Roels G.   Desombere I.   Garcon N.   Thiriart C.   Slaoui M.   Thoelen S.  

Vaccine, Vol. 18, Iss. 20, 2000-04 ,pp. : 2095-2101

Elsevier

Access to resources Recommend Favorite

Evaluation of B and T-cell responses in chimpanzees immunized with Hepagene(R), a hepatitis B vaccine containing pre-S1, pre-S2 and S gene products

By Pride M.W.   Bailey C.R.   Muchmore E.   Thanavala Y.  

Vaccine, Vol. 16, Iss. 6, 1998-04 ,pp. : 543-550

Elsevier

Access to resources Recommend Favorite

Effect of monophosphoryl lipid A (MPL ( R)) on T-helper cells when administered as an adjuvant with pneumocococcal-CRM 197 conjugate vaccine in healthy toddlers

By Vernacchio L.   Bernstein H.   Pelton S.   Allen C.   MacDonald K.   Dunn J.   Duncan D.D.   Tsao G.   LaPosta V.   Eldridge J.   Laussucq S.   Ambrosino D.M.   Molrine D.C.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3658-3667

Elsevier

Access to resources Recommend Favorite

Potentiation by a novel alkaloid glycoside adjuvant of a protective cytotoxic T cell immune response specific for a preerythrocytic malaria vaccine candidate antigen

By Heal K.G.   Sheikh N.A.   Hollingdale M.R.   Morrow W.J.W.   Taylor-Robinson A.W.  

Vaccine, Vol. 19, Iss. 30, 2001-07 ,pp. : 4153-4161

Elsevier

Access to resources Recommend Favorite